Reports
Sale
Global Inhaled Nitric Oxide Market Size, Growth, Trends, Forecast: By Strength: 100 ppm, 800 ppm, Others; By Purity: 99.92% Purity, 99.99% Purity, Others; By Applications: Chronic Obstructive Pulmonary Disease (COPD), Others; By End User; By Distribution Channel; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Inhaled Nitric Oxide Market Overview
3.1 Global Inhaled Nitric Oxide Market Historical Value (2017-2023)
3.2 Global Inhaled Nitric Oxide Market Forecast Value (2024-2032)
4 Global Inhaled Nitric Oxide Market Landscape
4.1 Global Inhaled Nitric Oxide Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Inhaled Nitric Oxide Product Landscape
4.2.1 Analysis by Strength
4.2.2 Analysis by Purity
4.2.3 Analysis by Applications
4.2.4 Analysis by Distribution Channel
5 Global Inhaled Nitric Oxide Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Inhaled Nitric Oxide Market Segmentation
6.1 Global Inhaled Nitric Oxide Market by Strength
6.1.1 Market Overview
6.1.2 100 ppm
6.1.3 800 ppm
6.1.4 Others
6.2 Global Inhaled Nitric Oxide Market by Purity
6.2.1 Market Overview
6.2.2 99.92% Purity
6.2.3 99.99% Purity
6.2.4 Others
6.3 Global Inhaled Nitric Oxide Market by Applications
6.3.1 Market Overview
6.3.2 Chronic Obstructive Pulmonary Disease (COPD)
6.3.3 Neonatal Respiratory Treatment
6.3.4 Tuberculosis Treatment
6.3.5 Acute Respiratory Distress Syndrome (ARDS)
6.3.6 Malaria Treatment
6.3.7 Others
6.4 Global Inhaled Nitric Oxide Market by End User
6.4.1 Market Overview
6.4.2 Clinics
6.4.3 Hospitals
6.4.4 Others
6.5 Global Inhaled Nitric Oxide Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Hospital Pharmacy
6.5.3 Retail Pharmacy
6.5.4 Online Pharmacy
6.5.5 Others
6.6 Global Inhaled Nitric Oxide Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Inhaled Nitric Oxide Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Inhaled Nitric Oxide Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Inhaled Nitric Oxide Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Inhaled Nitric Oxide Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Inhaled Nitric Oxide Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Mallinckrodt
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Linde plc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Air Liquide
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 BOC Limited
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bellerophon Therapeutics
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Beyond Air Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Halma plc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 VERO Biotech,
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Nu-Med Plus
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Getinge AB
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Merck KGaA
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Genosys Informatics
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Geno
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Perma Pure LLC
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Inhaled Nitric Oxide Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global inhaled nitric oxide market attained a value of nearly USD 800.00 million.
The market is estimated to grow at a CAGR of 8.1% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 1,612.69 million by 2032.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the industry, such as the rising cases of breathing problems among the geriatrics and new born babies, growing adoption of the product in hospitals, surgical centres and clinics, changing patient preference towards minimally-invasive treatments, and rising healthcare expenditure in the emerging economies are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing application of inhaled nitric oxide in the healthcare industry and the rapid technological advancements.
Neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS), among others are the major applications of the product.
The major players in the industry are Bellerophon Therapeutics Inc., Air Liquide Group, BOC Limited, and Vero Biotech, LLC, among others.
Analyst Review
The global inhaled nitric oxide market attained a value of USD 800.00 million in 2023, driven by the rising cases of breathing problems among the geriatrics and new born babies. Aided by the growing patient inclination towards minimally-invasive treatments, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 8.1%. The market is projected to reach USD 1,612.69 million by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The significant applications of the product include neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS), among others. The major regional markets for inhaled nitric oxide are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Bellerophon Therapeutics Inc., Air Liquide Group, BOC Limited, and Vero Biotech, LLC, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER